Lockheed Martin has returned to invest in Main Sequence Ventures’ second fundraise having previously committed to its Csiro-mandated first fund.
Australia-based venture capital firm Main Sequence Ventures secured A$250m ($194m) of capital commitments for its second fund yesterday, from investors including aerospace and defence manufacturer Lockheed Martin. The fund’s other limited partners include Singaporean state-owned investment firm Temasek, superannuation fund HostPlus, venture capital firm Horizons Ventures and unspecified family offices and individual investors represented by…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.